{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-008633","form_type":"8-K","ticker":"NXTC","cik":"0001661059","company_name":"NextCure, Inc.","filed_at":"2025-06-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.245355+00:00","generated_at":"2026-05-19T06:34:40.952316+00:00","sec_items":["1.01","3.02","7.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"NextCure licenses ADC SIM0505 from Simcere Zaiming in deal worth up to $745M","bullets":["Upfront cash $12M + $5M payable upon financing or by Dec 31, 2025; milestones up to $745M plus tiered royalties up to double digits.","Private placement: Simcere affiliate buys 4,063,633 shares at $0.492/share for $2M; registration rights granted.","SIM0505 (CDH6-targeting ADC) in Phase 1 in China; US Phase 1 expected Q3 2025 with initial data in H1 2026.","NextCure also obtains non-exclusive license to Simcere's linker/payload for a novel target ADC; Simcere retains Greater China rights.","Cash runway into mid-2026 based on current resources; company expects to exhaust sooner if assumptions prove incorrect."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-008633","json":"https://secwatch.observer/filing/0001558370-25-008633.json","markdown":"https://secwatch.observer/filing/0001558370-25-008633.md","text":"https://secwatch.observer/filing/0001558370-25-008633.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1661059/000155837025008633/0001558370-25-008633-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1661059/000155837025008633/nxtc-20250613x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T06:34:40.952316+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}